Bruton's Tyrosine Kinase Inhibitors [MoA] - N0000193934
Pharmacologic Class Information
Pharmacologic Code | N0000193934 |
Pharmacologic Name | Bruton's Tyrosine Kinase Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Bruton's Tyrosine Kinase Inhibitors
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Bruton's Tyrosine Kinase Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
72579-011 | Brukinsa | Non-Proprietary Name: Zanubrutinib | Capsule | Oral | Beigene Usa, Inc. | ACTIVE | |
0002-7026 | Jaypirca | Non-Proprietary Name: Pirtobrutinib | Tablet, Coated | Oral | Eli Lilly And Company | ACTIVE | |
0002-6902 | Jaypirca | Non-Proprietary Name: Pirtobrutinib | Tablet, Coated | Oral | Eli Lilly And Company | ACTIVE |